---
title: April News Round Up
description: "April’s top eye care news: best-selling drugs, smart tech launches, major acquisitions, and NHS cataract clinic investigations."
image: https://visionexecutives.com/hubfs/April%20News%20Round%20Up-1.png
---

[Skip to content](https://visionexecutives.com/blog/april-news-round-up-2#main-content)

[![Vision Executives Logo](https://visionexecutives.com/hubfs/Color%20logo%20with%20white%20text.svg)](https://www.visionexecutives.com/)

- [About](https://visionexecutives.com/about-us)
- Recruitment Services
  
  Show submenu for Recruitment Services 
  
    - [Retained Recruitment](https://visionexecutives.com/retained-recruitment)
    - [Contingency Recruitment](https://visionexecutives.com/contingency-recruitment)
    - [Our Candidates](https://visionexecutives.com/our-candidates)
    - [FREE Bad Hire Calculator](https://visionexecutives.com/bad-hire-calculator)
    - [FREE Job Survey](https://visionexecutives.com/free-job-survey)
- Candidate Services
  
  Show submenu for Candidate Services 
  
    - [Representing You](https://visionexecutives.com/representing-you)
    - [CV & LinkedIn Writing Service](https://visionexecutives.com/our-packages)
- [Our Vacancies](https://visionexecutives.com/vacancies)
- News & Insights
  
  Show submenu for News & Insights 
  
    - [Latest News & Articles](https://visionexecutives.com/blog)
    - [Eyewear & Optics Salary Report](https://visionexecutives.com/eyewear-optical-industry-salary-report)
    - [Optometrist & Ophthalmologist Salary Report](https://visionexecutives.com/optometrist-ophthalmologist-salary-report)
- [Contact](https://visionexecutives.com/contact-us)

Open main navigation

Close main navigation

- [About](https://visionexecutives.com/about-us)
- Recruitment Services
  
  Show submenu for Recruitment Services 
  
    - [Retained Recruitment](https://visionexecutives.com/retained-recruitment)
    - [Contingency Recruitment](https://visionexecutives.com/contingency-recruitment)
    - [Our Candidates](https://visionexecutives.com/our-candidates)
    - [FREE Bad Hire Calculator](https://visionexecutives.com/bad-hire-calculator)
    - [FREE Job Survey](https://visionexecutives.com/free-job-survey)
- Candidate Services
  
  Show submenu for Candidate Services 
  
    - [Representing You](https://visionexecutives.com/representing-you)
    - [CV & LinkedIn Writing Service](https://visionexecutives.com/our-packages)
- [Our Vacancies](https://visionexecutives.com/vacancies)
- News & Insights
  
  Show submenu for News & Insights 
  
    - [Latest News & Articles](https://visionexecutives.com/blog)
    - [Eyewear & Optics Salary Report](https://visionexecutives.com/eyewear-optical-industry-salary-report)
    - [Optometrist & Ophthalmologist Salary Report](https://visionexecutives.com/optometrist-ophthalmologist-salary-report)
- [Contact](https://visionexecutives.com/contact-us)
- [EYE-INTRO Login](https://vision-executives.i-intro.net/)

[EYE-INTRO Login](https://vision-executives.i-intro.net/)

# April News Round Up

May 13, 2025, 3:25:51 PM

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives)

Share: [facebook-f icon](http://www.facebook.com/share.php?u=https://visionexecutives.com/blog/april-news-round-up-2) [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://visionexecutives.com/blog/april-news-round-up-2) [twitter icon](https://twitter.com/intent/tweet?url=https://visionexecutives.com/blog/april-news-round-up-2) [pinterest-p icon](http://pinterest.com/pin/create/link/?url=https://visionexecutives.com/blog/april-news-round-up-2) [envelope icon](mailto:?body=https://visionexecutives.com/blog/april-news-round-up-2)

𝐀𝐩𝐫𝐢𝐥 𝐍𝐞𝐰𝐬 𝐑𝐨𝐮𝐧𝐝 𝐔𝐩

📢 𝐄𝐲𝐞𝐜𝐚𝐫𝐞 𝐀𝐦𝐨𝐧𝐠 𝐏𝐡𝐚𝐫𝐦𝐚’𝐬 𝐓𝐨𝐩 𝐒𝐞𝐥𝐥𝐢𝐧𝐠 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬   
Great to see two ophthalmic drugs among 2024's top sellers: Bayer's Eylea and Roche's Vabysmo.  
👁 [Bayer](https://www.linkedin.com/company/bayer/): Eylea, co-marketed with [Regeneron](https://www.linkedin.com/company/regeneron-pharmaceuticals/), remains a leading anti-VEGF treatment for AMD, DME, and retinal vein occlusion, continuing to dominate the retina market.  
👁 [Roche](https://www.linkedin.com/company/roche/): Vabysmo, a bispecific antibody targeting VEGF and Ang-2, is challenging Eylea’s dominance with strong uptake and extended dosing potential.  
👁 [Novartis](https://www.linkedin.com/company/novartis/) (Lucentis) and [AbbVie](https://www.linkedin.com/company/abbvie/) have promising ophthalmic drugs, but none broke into their top three bestsellers this year.

📢 𝐏𝐫𝐞𝐬𝐛𝐲𝐨𝐩𝐢𝐚 𝐔𝐩𝐝𝐚𝐭𝐞  
[Alcon](https://www.linkedin.com/company/alcon/) unveils Clareon PanOptix Pro Trifocal IOL (US launch May 2025), offering improved near-to-distance vision with 94% light utilisation.

[Orasis Pharmaceuticals](https://www.linkedin.com/company/orasis-pharmaceuticals/) launches QLOSI™ eye drops (US), enhancing near vision within 20 minutes, lasting up to 12 hours.

📢 𝐓𝐨𝐩𝐜𝐨𝐧 𝐆𝐨𝐞𝐬 𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐢𝐧 $2.31𝐁 𝐁𝐮𝐲𝐨𝐮𝐭 𝐰𝐢𝐭𝐡 𝐊𝐊𝐑 & 𝐉𝐈𝐂𝐂   
[Topcon Healthcare](https://www.linkedin.com/company/topcon-healthcare/) will go private in a $2.31B management buyout backed by KKR (majority stake) and JICC (minority stake). The move aims to drive long-term growth and strategic transformation, following a wider trend of Japanese firms enhancing competitiveness by exiting public markets.

📢 𝐑𝐚𝐲𝐧𝐞𝐫 𝐃𝐨𝐮𝐛𝐥𝐞𝐬 𝐈𝐎𝐋 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐂𝐚𝐩𝐚𝐜𝐢𝐭𝐲  
[Rayner](https://www.linkedin.com/company/rayner-iol/) has doubled IOL production to 4M units annually at its upgraded Worthing, UK facility, adding new automation, autoclaves, and energy-efficient tech. A new global warehouse near Gatwick, opened in 2024, further boosts global distribution.

📢 𝐀𝐥𝐜𝐨𝐧 𝐀𝐜𝐪𝐮𝐢𝐫𝐞𝐝 𝐌𝐚𝐣𝐨𝐫𝐢𝐭𝐲 𝐒𝐭𝐚𝐤𝐞 𝐢𝐧 𝐀𝐮𝐫𝐢𝐨𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐭𝐨 𝐀𝐝𝐯𝐚𝐧𝐜𝐞 𝐂𝐨𝐫𝐧𝐞𝐚𝐥 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲   
[Alcon](https://www.linkedin.com/company/alcon/) has acquired a majority stake in [Aurion Biotech](https://www.linkedin.com/company/aurion-biotech/), advancing its position in corneal cell therapy. Aurion’s lead candidate, AURN001, targets corneal endothelial disease and is heading into Phase 3 trials in late 2025. Aurion will operate independently, with Dr. Arnaud Lacoste as CEO.

📢 𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐂𝐚𝐭𝐚𝐫𝐚𝐜𝐭 𝐂𝐥𝐢𝐧𝐢𝐜𝐚 𝐔𝐧𝐝𝐞𝐫 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐠𝐚𝐭𝐢𝐨𝐧 𝐀𝐦𝐢𝐝 𝐍𝐇𝐒 𝐎𝐯𝐞𝐫𝐬𝐩𝐞𝐧𝐝 𝐚𝐧𝐝 𝐒𝐞𝐫𝐯𝐢𝐜𝐞 𝐂𝐨𝐧𝐜𝐞𝐫𝐧𝐬   
Private NHS cataract surgery providers are under investigation for inflated costs, unnecessary procedures, and financial incentives. NHS cataract spending has nearly doubled, from £420M in 2018–19 to £880M in 2023–24. Over 55% of NHS cataract surgeries are now outsourced to private clinics, which earned £536M in 2023–24, with £169M in profits.   
A [The Royal College of Ophthalmologists (RCOphth)](https://www.linkedin.com/company/the-royal-college-of-ophthalmologists/) survey found 67% of NHS leads believe outsourcing harms patient care, citing reduced training, staffing, and funding. Calls for urgent reform are growing to protect NHS eye care services.

## Related posts

[![](https://visionexecutives.com/hs-fs/hubfs/Alcon%20Acquires%20Majority%20Stake%20in%20Aurion%20Biotech.png?height=200&name=Alcon%20Acquires%20Majority%20Stake%20in%20Aurion%20Biotech.png)](https://visionexecutives.com/blog/alcon-acquires-majority-stake-in-aurion-biotech-to-advance-corneal-cell-therapy)

## [Alcon Acquires Majority Stake in Aurion Biotech to Advance Corneal Cell Therapy](https://visionexecutives.com/blog/alcon-acquires-majority-stake-in-aurion-biotech-to-advance-corneal-cell-therapy)

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives) 

 May 13, 2025, 3:58:30 PM

𝐀𝐥𝐜𝐨𝐧 𝐀𝐜𝐪𝐮𝐢𝐫𝐞𝐬 𝐌𝐚𝐣𝐨𝐫𝐢𝐭𝐲 𝐒𝐭𝐚𝐤𝐞 𝐢𝐧 𝐀𝐮𝐫𝐢𝐨𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐭𝐨...

[Read more](https://visionexecutives.com/blog/alcon-acquires-majority-stake-in-aurion-biotech-to-advance-corneal-cell-therapy)

[![](https://visionexecutives.com/hs-fs/hubfs/Pharma%20Giants%202024.png?height=200&name=Pharma%20Giants%202024.png)](https://visionexecutives.com/blog/eyecare-among-the-top-selling-medicines-of-pharma-2024)

## [Eyecare Among the Top Selling Medicines of Pharma 2024](https://visionexecutives.com/blog/eyecare-among-the-top-selling-medicines-of-pharma-2024)

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives) 

 May 13, 2025, 3:48:26 PM

#𝐄𝐲𝐞𝐜𝐚𝐫𝐞𝐀𝐦𝐨𝐧𝐠 𝐭𝐡𝐞 𝐓𝐡𝐞 𝐓𝐨𝐩 𝐒𝐞𝐥𝐥𝐢𝐧𝐠 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚...

[Read more](https://visionexecutives.com/blog/eyecare-among-the-top-selling-medicines-of-pharma-2024)

[![](https://visionexecutives.com/hs-fs/hubfs/Keratoconus%20Treatment.png?height=200&name=Keratoconus%20Treatment.png)](https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa)

## [FDA Accepts Glauko's NDA for Epioxa](https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa)

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives) 

 Mar 14, 2025, 8:44:08 AM

𝐅𝐃𝐀 𝐀𝐜𝐜𝐞𝐩𝐭𝐬 𝐆𝐥𝐚𝐮𝐤𝐨𝐬'𝐬 𝐍𝐃𝐀 𝐟𝐨𝐫 𝐄𝐩𝐢𝐨𝐱𝐚: 𝐀 𝐍𝐞𝐰 𝐄𝐫𝐚 𝐢𝐧...

[Read more](https://visionexecutives.com/blog/fda-accepts-glaukos-nda-for-epioxa)

[![Vision Executives Logo](https://visionexecutives.com/hubfs/Color%20logo%20with%20white%20text.svg "Vision Executives Logo")](https://visionexecutives.com/)

Vision Executives International Ltd  
HUB26  
Hunsworth Lane

Cleckheaton  
BD19 4LN  
​United Kingdom

 

[   +44 (0) 113490 0340](tel:4401134900340)

[mailto:info@visionexecutives.com](mailto:info@visionexecutives.com)   [info@visionexecutives.com](mailto:info@visionexecutives.com)  
<https://www.linkedin.com/company/vision-executives/?originalSubdomain=uk>  [Follow us on LinkedIn](https://www.linkedin.com/company/vision-executives/?originalSubdomain=uk)

- **Quick Links**
  
    - [Home](https://visionexecutives.com)
    - [About](https://visionexecutives.com/about-us)
    - [News & Insights](https://visionexecutives.com/blog)
    - [Contact us](https://visionexecutives.com/contact-us)
    - [Vacancies](https://visionexecutives.com/vacancies)
    - [Our Candidates](https://visionexecutives.com/our-candidates)
    - [Bad Hire Calculator](https://visionexecutives.com/bad-hire-calculator)
    - [FREE Job Survey](https://visionexecutives.com/free-job-survey)
    - EYE-INTRO Login
- **Services**
  
    - [Retained Recruitment](https://visionexecutives.com/retained-recruitment)
    - [Contingency Recruitment](https://visionexecutives.com/contingency-recruitment)
    - [Representing You](https://visionexecutives.com/representing-you)
    - [CV & LinkedIn Writing Service](https://visionexecutives.com/our-packages)

<iframe class="hs-responsive-embed-iframe" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: none;" xml="lang" src="https://www.google.com/maps/embed?pb=!1m14!1m8!1m3!1d1236136.8347097263!2d-2.72842621664985!3d52.66548923511256!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x487be19725160b51%3A0xb3b9cbfc92600618!2sVision%20Executives!5e0!3m2!1sen!2suk!4v1689253568813!5m2!1sen!2suk" width="600" height="450" allowfullscreen loading="lazy" data-service="google-maps"></iframe>

---

Website designed by [Xtra Mile Marketing](https://www.xtramilemarketing.co.uk/)

Copyright © 2026, Vision Executives

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Vision Executives",
    "url" : "https://visionexecutives.com/blog/author/vision-executives"
  },
  "dateModified" : "2025-05-13T14:25:51.995Z",
  "datePublished" : "2025-05-13T14:25:51.000Z",
  "headline" : "April News Round Up",
  "image" : [ "https://visionexecutives.com/hubfs/April%20News%20Round%20Up-1.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://visionexecutives.com/blog/april-news-round-up-2",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://visionexecutives.com/hubfs/Globals/vision%20executives%20logo.png"
    },
    "name" : "Vision Executives"
  }
}
```